Sugi Predict

Sugi Predict / Compounds / SCHEMBL2863002

SCHEMBL2863002

SCHEMBL2863002

COc1ccc(C)c(-n2nc3c(c2N)c(=O)[nH]c2cc(O)ccc23)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.39
▸ ALDH1A1 P00352 6/20 0.38
▸ GAA P10253 6/20 0.38
▸ HPGD P15428 4/20 0.38
▸ GLA P06280 1/20 0.38
▸ EPHB4 P54760 1/20 0.37
▸ ROCK2 O75116 1/20 0.36
▸ TYMS P04818 1/20 0.36
▸ MAPT P10636 4/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.35
▸ USP2 O75604 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ PDE2A O00408 1/20 0.35
▸ STING1 Q86WV6 1/20 0.34
▸ KMT2A Q03164 4/20 0.34
▸ MEN1 O00255 3/20 0.34
▸ HTT P42858 2/20 0.34
▸ HCRTR1 O43613 1/20 0.34
▸ ESR1 P03372 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2866719 0.89 PDE2A (0.43) KDM4EALDH1A1GAAHPGDROCK2
SCHEMBL2868587 0.87 KDM4E (0.38) KDM4EALDH1A1GAAHPGDGLA
SCHEMBL2868559 0.87 ADORA3 (0.47) KDM4EALDH1A1HPGDEPHB4MAPT
SCHEMBL2867465 0.87 EGFR (0.37) KDM4EALDH1A1GAAHPGDEPHB4
SCHEMBL2864971 0.86 CHEK1 (0.45) KDM4EALDH1A1GAAHPGDGLA
SCHEMBL2857838 0.86 PARP1 (0.39) KDM4EALDH1A1GAAHPGDGLA
SCHEMBL2870423 0.86 KDM4E (0.38) KDM4EALDH1A1GAAHPGDEPHB4
SCHEMBL2862983 0.86 GAA (0.46) KDM4EALDH1A1GAAMAPTKMT2A
SCHEMBL2872669 0.85 ESR2 (0.39) KDM4EALDH1A1GAAEPHB4TYMS
SCHEMBL2860224 0.85 RET (0.39) KDM4EALDH1A1GAAHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7842701-B2 Pyrazoloquinolone derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-11-30 — — US disclosed
US-7842701-B2 Pyrazoloquinolone derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-11-30 — — US disclosed
US-7842701-B2 Pyrazoloquinolone derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-11-30 — — US disclosed
US-20070281963-A1 Pyrazoloquinolone Derivative And Use Thereof TAKEDA PHARMACEUTICAL COMPANY (JP) 2007-12-06 — — US disclosed
US-20070281963-A1 Pyrazoloquinolone Derivative And Use Thereof TAKEDA PHARMACEUTICAL COMPANY (JP) 2007-12-06 — — US disclosed
US-20070281963-A1 Pyrazoloquinolone Derivative And Use Thereof TAKEDA PHARMACEUTICAL COMPANY (JP) 2007-12-06 — — US disclosed
EP-1719771-A1 PYRAZOLOQUINOLONE DERIVATIVE AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2006-11-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070281963-A1 Pyrazoloquinolone Derivative And Use Thereof MAP3K20, MAP4K5, MAP4K3 KDM4E 1057/4885ALDH1A1 2391/4885GAA 4868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.